TFF PHARMACEUTICALS, INC. Operating Lease, Payments
TFF PHARMACEUTICALS, INC. reported Operating Lease, Payments of $68.14 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2024-09-30 was $23.06K, a 3.54% increase year-over-year.
- TFF PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2024-06-30 was $22.80K, a 3.58% increase year-over-year.
- TFF PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2024-03-31 was $22.27K, a 3.66% increase year-over-year.
- TFF PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2023-12-31 was $49.48K.
- TFF PHARMACEUTICALS, INC. operating lease, payments for fiscal 2023 was $115.25K, a 39.57% decline from fiscal 2022.
- TFF PHARMACEUTICALS, INC. operating lease, payments for fiscal 2022 was $190.72K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-09-30 | $23.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $45.86K derived: sum of 2 quarters · filed 2024-11-20 | $68.14K 10-Q · filed 2024-11-20 | $117.62K derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-06-30 | $22.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $45.08K 10-Q · filed 2024-08-14 | $94.55K derived: sum of 3 quarters · filed 2024-08-14 | $116.83K derived: sum of 4 quarters · filed 2024-11-20 |
| 2024-03-31 | $22.27K 10-Q · filed 2024-05-14 | $71.75K derived: sum of 2 quarters · filed 2024-05-14 | $94.03K derived: sum of 3 quarters · filed 2024-11-20 | $116.04K derived: sum of 4 quarters · filed 2024-11-20 |
| 2023-12-31 | $49.48K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $71.75K derived: sum of 2 quarters · filed 2024-11-20 | $93.77K derived: sum of 3 quarters · filed 2024-11-20 | $115.25K 10-K · filed 2024-03-28 |
| 2023-09-30 | $22.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $44.29K derived: sum of 2 quarters · filed 2024-11-20 | $65.78K 10-Q · filed 2024-11-20 | |
| 2023-06-30 | $22.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $43.50K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $21.49K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $190.72K 10-K · filed 2024-03-28 |